Aziz Ghaderpour

Business Development Deputy General Manager at Shaperon Inc.

Presenter

Aziz Ghaderpour, Ph.D. is Deputy General Manager and Business Development Team Lead at Shaperon Inc., a KOSDAQ-listed, clinical-stage biotechnology company developing first-in-class inflammasome inhibitors and nanobody therapeutics for immune-mediated inflammatory diseases and cancer. Dr. Ghaderpour joined Shaperon in 2021 and currently leads the company's global partnering, licensing-out/in, and strategic collaboration activities, overseeing scientific and commercial positioning, valuation rationale, investor-facing materials, due diligence support, and engaging with pharmaceutical, biotechnology, and investment partners. He previously led dermatology R&D programs at Shaperon, contributing to the advancement of NuGel into US Phase 2b clinical trials. Dr. Ghaderpour holds a Ph.D. in Immunology from Seoul National University College of Medicine and brings over 16 years of experience spanning clinical diagnostics, translational R&D, and global business development. He was recognized as a Top Ph.D. Graduate at Seoul National University College of Medicine.